Schizophrenia Research
Volume 77, Issue 1 , Pages 99-104 , 1 September 2005

A prospective 3-year longitudinal study of cognitive predictors of relapse in first-episode schizophrenic patients

  • Eric Yu-Hai Chen

      Affiliations

    • Department of Psychiatry, University of Hong Kong, Queen Mary Hospital, Pokfulam Road, Hong Kong
    • Corresponding Author InformationCorresponding author. Tel.: +852 28554488; fax: +852 28551345.
    • ,
  • Christy Lai-Ming Hui

      Affiliations

    • Department of Psychiatry, University of Hong Kong, Queen Mary Hospital, Pokfulam Road, Hong Kong
    • ,
  • Eva Lai-Wah Dunn

      Affiliations

    • Department of Psychiatry, Pamela Youde Nethersole Eastern Hospital, Hong Kong
    • ,
  • May Yin-King Miao

      Affiliations

    • Department of Psychiatry, Pamela Youde Nethersole Eastern Hospital, Hong Kong
    • ,
  • Wai-Song Yeung

      Affiliations

    • Department of Psychiatry, Pamela Youde Nethersole Eastern Hospital, Hong Kong
    • ,
  • Chi-Keung Wong

      Affiliations

    • Department of Psychiatry, Pamela Youde Nethersole Eastern Hospital, Hong Kong
    • ,
  • Wah-Fat Chan

      Affiliations

    • Department of Psychiatry, Pamela Youde Nethersole Eastern Hospital, Hong Kong
    • ,
  • Wai-Nang Tang

      Affiliations

    • Department of Psychiatry, Pamela Youde Nethersole Eastern Hospital, Hong Kong

Received 1 December 2004 ,Revised 28 February 2005 ,Accepted 28 February 2005.

References 

  1. Abi-Dargham A. Do we still believe in the dopamine hypothesis? New data bring new evidence. International Journal of Neuropsychopharmacology. 2004;7(Suppl. 1):S1–S5
  2. American Psychiatric Association . DSM-IV: Diagnostic and Statistical Manual of Mental Disorders. 4th edition. Washington, DC: American Psychiatric Association; 1994;
  3. Brake WG, Flores G, Francis D, Meaney MJ, Srivastava LK, Gratton A. Enhanced nucleus accumbens dopamine and plasma corticosterone stress responses in adult rats with neonatal excitotoxic lesions to the medial prefrontal cortex. Neuroscience. 2000;96:687–695
  4. Carpenter WT. Maintenance therapy of persons with schizophrenia. Journal of Clinical Psychiatry. 1996;57(Suppl. 9):10–18
  5. Chen EY, Kwok CL, Chen RY, Kwong PP. Insight changes in acute psychotic episodes: a prospective study of Hong Kong Chinese patients. Journal of Nervous and Mental Disease. 2001;189:24–30
  6. Deutch AY. The regulation of subcortical dopamine systems by the prefrontal cortex: interactions of central dopamine systems and the pathogenesis of schizophrenia. Journal of Neural Transmission. Supplementum. 1992;36:61–89
  7. Gilbert PL, Harris MJ, McAdams LA, Jeste DV. Neuroleptic withdrawal in schizophrenic patients. A review of the literature. Archives of General Psychiatry. 1995;52(3):173–188
  8. Grace AA. Gating of information flow within the limbic system and the pathophysiology of schizophrenia. Brain Research Reviews. 2000;31:330–341
  9. Hershon HI, Kennedy PF, McGuire RJ. Persistence of extra-pyramidal disorders and psychiatric relapse after withdrawal of long-term phenothiazine therapy. British Journal of Psychiatry. 1972;120(554):41–50
  10. Hong Kong Psychological Society . The Wechsler Adult Intelligence Scale-Revised (Cantonese version). Hong Kong: Hong Kong Psychological Society; 1989;
  11. Kay SR, Fiszbein A, Opler LA. Positive and negative symptom scale (PANSS) for schizophrenia. Schizophrenia Bulletin. 1988;13:21–76
  12. Koren D, Seidman LJ, Poyurovsky M, Goldsmith M, Viksman P, Zichel S, et al. The neuropsychological basis of insight in first-episode schizophrenia: a pilot metacognitive study. Schizophrenia Research. 2004;70:195–202
  13. Lieberman JA, Kane JM, Sarantakos S, Gadaleta D, Woerner M, Alvir J, et al. Prediction of relapse in schizophrenia. Archives of General Psychiatry. 1987;44(7):597–603
  14. Lieberman JA, Alvir J, Geisler S, Ramos-Lorenzi J, Woerner M, Novacenko H, et al. Methylphenidate response, psychopathology and tardive dyskinesia as predictors of relapse in schizophrenia. Neuropsychopharmacology. 1994;11:107–118
  15. Lysaker PH, Lancaster RS, Davis LW, Clements CA. Patterns of neurocognitive deficits and unawareness of illness in schizophrenia. Journal of Nervous and Mental Disease. 2003;191:38–44
  16. Nelson HE. A modified card sorting test sensitive to frontal lobe defects. Cortex. 1976;12:313–324
  17. Prien RF, Cole JO, Belkin NF. Relapse in chronic schizophrenics following abrupt withdrawal of tranquillizing medication. British Journal of Psychiatry. 1969;115(523):679–686
  18. Ram R, Bromet EJ, Eaton WW, Pato C, Schwartz JE. The natural course of schizophrenia: a review of first-admission studies. [Review] [98 refs] Schizophrenia Bulletin. 1992;18(2):185–207
  19. Rassidakis NC, Kondakis X, Papanastassiou A, Michalakeas A. Withdrawal of antipsychotic drugs from chronic psychiatric patients. Bulletin of the Menninger Clinic. 1970;34(4):216–222
  20. Robinson D, Woerner MG, Alvir JM, Bilder R, Goldman R, Geisler S, et al. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Archives of General Psychiatry. 1999;56(3):241–247
  21. Robinson DG, Woerner MG, Alvir JM, Bilder RM, Hinrichsen GA, Lieberman JA. Predictors of medication discontinuation by patients with first-episode schizophrenia and schizoaffective disorder. Schizophrenia Research. 2002;57(2-3):209–219
  22. Rossell SL, Coakes J, Shapleske J, Woodruff PW, David AS. Insight: its relationship with cognitive function, brain volume and symptoms in schizophrenia. Psychological Medicine. 2003;33:111–119
  23. Zander KJ, Fischer B, Zimmer R, Ackenheil M. Long-term neuroleptic treatment of chronic schizophrenic patients: clinical and biochemical effects of withdrawal. Psychopharmacology. 1981;73(1):43–47

PII: S0920-9964(05)00086-1

doi: 10.1016/j.schres.2005.02.020

Schizophrenia Research
Volume 77, Issue 1 , Pages 99-104 , 1 September 2005

Article Tools